Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Tolerability of high-dose topical tretinoin: the Veterans Affairs Topical Tretinoin Chemoprevention Trial
British Journal of Dermatology, 08/10/09
Geng A et al. – Overall, the tolerability level of topical tretinoin was high in this study population, with almost 40% of the tretinoin group reporting no side–effects, and the majority tolerating at least once–daily dosing at 6–month follow–up. High–dose topical tretinoin is feasible for long–term use in this population.
Related Articles
Arsenic trioxide as first-line treatment for acute promyelocytic leukemia
American Journal of Health-System Pharmacy, 10/26/09
Relevance Score: 84%
All-trans retinoic acid as a novel therapeutic strategy for Alzheimer's disease
Expert Review of Neurotherapeutics, 11/18/09
Relevance Score: 77%
Enlarging vesicular peeling of the palms
The Clinical Advisor, 11/04/09
Relevance Score: 77%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
A Comparative Study of Topical 5-Aminolevulinic Acid Incubation Times in Photodynamic Therapy with Intense Pulsed Light for the Treatment of Inflammatory Acne
Dermatologic Surgery, 12/09/09
Disseminated Herpes Zoster Mimicking Rheumatoid Vasculitis in a Rheumatoid Arthritis Patient on Etanercept
Dermatology, 12/08/09
Late-Onset Immune-Mediated Adverse Effects after Poly-L-Lactic Acid Injection in Non-HIV Patients: Clinical Findings and Long-Term Follow-Up
Dermatology, 12/08/09
Sponsor
Article Search
Sponsor


See Latest Articles


